GlassScriptPhysician profile
Pablo M Elizalde
NPI 1831290055
$8,103.37
in general payments reported to CMS, 2019-2025
32 companies · $1,439 in 2025
The $1,439 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,077 · 2020: $527 · 2021: $858 · 2022: $1,316 · 2023: $1,392 · 2024: $1,495 · 2025: $1,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,288 · Education: $37.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,287.94 |
| Education | $37.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,157.47 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $975.00 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $837.42 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $786.92 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $627.42 | 2019-2024 | Xarelto |
| Medtronic, INC. | $612.21 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Linq II |
| Novartis Pharmaceuticals Corporation | $596.54 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $567.98 | 2019-2025 | Jardiance |
| Cvrx, INC. | $399.76 | 2023-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $278.53 | 2022-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $274.03 | 2019-2025 | |
| Abbott Laboratories | $110.51 | 2019 | |
| Abiomed | $105.68 | 2021-2024 | Impella |
| Boston Scientific Corporation | $91.45 | 2022-2025 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $80.92 | 2019-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $77.62 | 2022-2023 | |
| Lexicon Pharmaceuticals, INC. | $72.07 | 2023-2024 | Inpefa |
| Cardiva Medical, INC. | $56.98 | 2024 | Optowire, Savvywire |
| Bayer Healthcare Pharmaceuticals INC. | $55.11 | 2022-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $51.54 | 2022-2023 | Arcalyst |
| Esperion Therapeutics, INC. | $45.00 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $39.33 | 2022-2023 | Definity |
| Alnylam Pharmaceuticals INC. | $35.74 | 2019 | |
| Medtronic Vascular, INC. | $28.88 | 2019-2020 | |
| Astellas Pharma US INC | $26.92 | 2020 | |
| Novo Nordisk INC | $24.28 | 2025 | Wegovy |
| Aegerion Pharmaceuticals, INC. | $16.97 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.79 | 2019 | |
| Celonova Biosciences, INC. | $15.47 | 2020 | |
| Baxter Healthcare | $14.32 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Medicomp INC | $13.02 | 2022 | |
| Bardy Diagnostics, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pablo Elizalde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.